AKTS
NASDAQ HealthcareAktis Oncology, Inc. - Common stock
Biotechnology
📊 Market Data
| Price | $18.29 |
|---|---|
| Volume | 217,793 |
| Market Cap | 1.01B |
| RSI (14-Day) | 45.7 |
| 52-Week High | $29.16 |
| 52-Week Low | $16.80 |
| Forward P/E | -10.61 |
| Price / Book | -0.11 |
🎯 Investment Strategy Scores
How AKTS scores across each investment strategy. Higher is better for that strategy's goals.
💰 Dividend Daddy
29/100
High dividend yield + low volatility
🚀 Moon Shot
7/100
High growth potential (high beta + oversold)
🔪 Falling Knife
39/100
Contrarian plays (oversold + below moving average)
🎈 Over-Hyped
65/100
Overbought stocks (potential short candidates)
🐋 Institutional Whale
26/100
Large-cap, institutional-quality stocks
Find AKTS in your text
Paste any text on the homepage — the tool will extract AKTS and other hidden tickers.
Disclaimer: This data is for educational and entertainment purposes only and does not constitute financial advice. Market data may be delayed. Always do your own research before making investment decisions.